The editors asked two members of the Psychopharmacologic Drugsand Pediatric Advisory Committees of the Food and Drug Administrationto comment on the committees' recent recommendations regardingthe use of antidepressant medications in children and adolescents.
Their responses follow.
There is great concern that antidepressants used in childrenand adolescents may paradoxically increase their risk of suicidalthoughts and behavior. Is this concern valid, and if so, howshould it modify our clinical approach to pediatric depression?
Twenty-five years ago, long before the introduction of selectiveserotonin-reuptake inhibitors (SSRIs), the adolescent suiciderate was increasing rapidly, having tripled over . . . [Full Text of this Article]
Source Information
From the Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh.
This article has been cited by other articles:
(2008). Practice Parameter for the Assessment and Treatment of Children and Adolescents With Depressive Disorders. Focus
6: 379-400
[Abstract][Full Text]
Olfson, M., Marcus, S. C., Druss, B. G.
(2008). Effects of Food and Drug Administration Warnings on Antidepressant Use in a National Sample. Arch Gen Psychiatry
65: 94-101
[Abstract][Full Text]
Hammad, T. A
(2007). Review: Benefits of antidepressants outweigh risks of suicidal ideation and attempts in children and adolescents. Evid. Based Ment. Health
10: 108-108
[Full Text]
Libby, A. M., Brent, D. A., Morrato, E. H., Orton, H. D., Allen, R., Valuck, R. J.
(2007). Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs. Am. J. Psychiatry
164: 884-891
[Abstract][Full Text]
Li, J. S., Eisenstein, E. L., Grabowski, H. G., Reid, E. D., Mangum, B., Schulman, K. A., Goldsmith, J. V., Murphy, M. D., Califf, R. M., Benjamin, D. K. Jr
(2007). Economic Return of Clinical Trials Performed Under the Pediatric Exclusivity Program. JAMA
297: 480-488
[Abstract][Full Text]
McKeown, R. E., Cuffe, S. P., Schulz, R. M.
(2006). US Suicide Rates by Age Group, 1970-2002: An Examination of Recent Trends. Am. J. Public Health
96: 1744-1751
[Abstract][Full Text]
Olfson, M., Marcus, S. C., Shaffer, D.
(2006). Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study.. Arch Gen Psychiatry
63: 865-872
[Abstract][Full Text]
Kaizar, E. E, Greenhouse, J. B, Seltman, H., Kelleher, K.
(2006). Do antidepressants cause suicidality in children? A Bayesian meta-analysis. Clin Trials
3: 73-98
[Abstract]
Hammad, T. A., Laughren, T., Racoosin, J.
(2006). Suicidality in pediatric patients treated with antidepressant drugs.. Arch Gen Psychiatry
63: 332-339
[Abstract][Full Text]
Dopheide, J. A.
(2006). Recognizing and treating depression in children and adolescents. Am J Health Syst Pharm
63: 233-243
[Abstract][Full Text]
TONKIN, A., JUREIDINI, J.
(2005). Wishful thinking: antidepressant drugs in childhood depression. Br. J. Psychiatry
187: 304-305
[Full Text]
Sewitch, M. J., Blais, R., Rahme, E., Bexton, B., Galarneau, S.
(2005). Pharmacologic Response to Depressive Disorders Among Adolescents. Psychiatr. Serv.
56: 1089-1097
[Abstract][Full Text]
Clouse, R E, Lustman, P J
(2005). USE OF PSYCHOPHARMACOLOGICAL AGENTS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS. Gut
54: 1332-1341
[Full Text]
Gould, M. S., Marrocco, F. A., Kleinman, M., Thomas, J. G., Mostkoff, K., Cote, J., Davies, M.
(2005). Evaluating Iatrogenic Risk of Youth Suicide Screening Programs: A Randomized Controlled Trial. JAMA
293: 1635-1643
[Abstract][Full Text]
Martin, A., Young, C., Leckman, J. F., Mukonoweshuro, C., Rosenheck, R., Leslie, D.
(2005). Risk of Mania With Antidepressants--Reply. Arch Pediatr Adolesc Med
159: 298-299
[Full Text]
Fochtmann, L. J., Gelenberg, A. J.
(2005). Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition. Focus
3: 34-42
[Full Text]
Previous
